ArticleFrontiers in pediatrics2025
Clinical presentation and outcomes of diabetic ketoacidosis in pediatric and adolescent patients at a tertiary hospital in Jordan.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Early vs. late initiation of long-acting basal insulin during IV insulin in pediatric diabetic ketoacidosis: a GRADE-assessed systematic review and meta-analysis.European journal of pediatrics · 2025Pooled it
- Precipitating Factors, Complications, and Outcomes of Diabetic Ketoacidosis (DKA) in Adults and Pediatrics: A Descriptive Study from Two Tertiary Centers in Riyadh, Saudi Arabia.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Diabetic ketoacidosis (DKA) remains a serious and potentially life-threatening complication of diabetes in children and adolescents, particularly in resource-limited settings, with overall mortality of 3.4%-13.4% in developing countries. Understanding the clinical presentation, treatment outcomes, and complication rates is essential to improving care and reducing morbidity. Methods: A retrospective analysis was conducted on pediatric patients aged 2-16 years admitted with DKA to King Abdulla University Hospital (KAUH) between 2017 and 2023. Data were collected on age, diagnosis status, DKA severity, and clinical outcomes. Results: DKA was most common between 6 and 12 years old (67.8%) with mean age of 9 (IQR = 5). More than two thirds of children were newly diagnosed upon admission (72.4%) while the remainder were known cases of T1DM, 41.1% of patients had severe DKA while 35.7% had moderate DKA. No mortality was reported during the study period. Conclusion: DKA remains a frequent presentation among newly diagnosed pediatric diabetes cases in this setting, with a high proportion of moderate to severe presentations. Despite the severity, no deaths were reported, highlighting the effectiveness of management protocols at KAUH. Continued efforts are needed to improve early diagnosis and reduce complication rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.